Difference between revisions of "LINC00319"
| Line 16: | Line 16: | ||
LncBook ID: [https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323] | LncBook ID: [https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
===Function=== | ===Function=== | ||
| Line 29: | Line 21: | ||
Biological Process: pathogenic process | Biological Process: pathogenic process | ||
| − | |||
| − | |||
===Characteristics === | ===Characteristics === | ||
| Line 42: | Line 32: | ||
[[File:Model of hLarp7 recognition of the 7SK.png|right|thumb|Model of hLarp7 recognition of the 7SK 3′end and mechanism of assembly of core 7SK RNP([https://www.ncbi.nlm.nih.gov/pubmed/29946027 (Eichhorn 2018)])]] | [[File:Model of hLarp7 recognition of the 7SK.png|right|thumb|Model of hLarp7 recognition of the 7SK 3′end and mechanism of assembly of core 7SK RNP([https://www.ncbi.nlm.nih.gov/pubmed/29946027 (Eichhorn 2018)])]] | ||
| + | Linc00319 promotes cell proliferation and invasion in lung cancer cells by directly binding with and downregulating the tumor suppressor miR-32.<ref name="ref1" /> | ||
===Disease=== | ===Disease=== | ||
| − | + | lung cancer <ref name="ref1" /> | |
===Evolution=== | ===Evolution=== | ||
Revision as of 05:19, 12 August 2019
Contents
Annotation
Name
Approved symbol: LINC00319
Approved name: long intergenic non-protein coding RNA 319
HGNC ID: HGNC:19730
Previous symbols: C21orf125; NCRNA00319
Previous names: chromosome 21 open reading frame 125; non-protein coding RNA 319
Alias symbols: PRED49; FLJ38036
RefSeq ID: NR_026960
LncBook ID: HSALNT0289323
Function
Function Mechanism: ceRNA (PMID:28800794)
Biological Process: pathogenic process
Characteristics
Functional domains of 7SK RNA((Diribarne 2009))
Expression
Regulation
Function
Model of hLarp7 recognition of the 7SK 3′end and mechanism of assembly of core 7SK RNP((Eichhorn 2018))
Linc00319 promotes cell proliferation and invasion in lung cancer cells by directly binding with and downregulating the tumor suppressor miR-32.[1]
Disease
lung cancer [1]
Evolution
Please input evolution information here.
Labs working on this lncRNA
- College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi 712100, China.[1]
